Fol. Biol. 2011, 57, 242-247

https://doi.org/10.14712/fb2011057060242

Urinary BLCA-4 is Highly Specific for Detection of Bladder Cancer in Chinese Han Population and Is Related to Tumour Invasiveness

C. C. Feng1, P. H. Wang2, M. Guan3, H. W. Jiang1, H. Wen1, Qiang Ding1, Zhong Wu1

1Department of Urology, Huashan Hospital, Fudan University, Shanghai, PR China
2Department of Surgery, Huashan Hospital, Fudan University, Shanghai, PR China
3Centre of Laboratory Medicine, Huashan Hospital, Fudan University, Shanghai, PR China

Received May 2011
Accepted June 2011

References

1. AUA Clinical Guidelines, Bladder Cancer (2010) http://www.auanet.org/content/guidelines-and-quality-care/clinicalguidelines/main-reports/bladcan07/chapter1.pdf
2. Babjuk, M., Oosterlinck, W., Sylvester, R., Kassinen, E., Böhle, A., Palou, J. (2008) EAU guidelines on non-muscle invasive urothelial carcinoma of the bladder. Eur. Urol. 54, 303-314. <https://doi.org/10.1016/j.eururo.2008.04.051>
3. Botteman, M. F., Pashos, C. L., Redaelli, A., Laskin, B., Hauser, R. (2003) The health economics of bladder cancer: a comprehensive review of the published literature. Pharmacoeconomics 21, 1315-1330. <https://doi.org/10.1007/BF03262330>
4. Feng, C., Guan, M., Ding, Q., Zhang, Y., Jiang, H., Wen, H., Wang, P., Wu, Z. (2011a) Expression of pigment epithelium-derived factor in bladder tumour is correlated with interleukin-8 yet not with interleukin-1α. J. Huazhong. Univ. Sci. Technol. Med. Sci. 31, 21-25. <https://doi.org/10.1007/s11596-011-0144-6>
5. Feng, C., Wang, P., Ding, Q., Guan, M., Zhang, Y., Jiang, H., Wen, H., Wu, Z. (2011b) Expression of pigment epithelium-derived factor and tumor necrosis factor-α is correlated in bladder tumor and is related to tumor angiogenesis. Urol. Oncol. <https://doi.org/10.1016/j.urolonc.2010.12.001>
6. Gaston, K. E., Grossman, H. B. (2010) Proteomic assays for the detection of urothelial cancer. Methods Mol. Biol. 641, 303-323. <https://doi.org/10.1007/978-1-60761-711-2_17>
7. Getzenberg, R. H., Konety, B. R., Oeler, T. A., Quigley, M. M., Hakam, A., Becich, M. J., Bahnson, R. R. (1996) Bladder cancer-associated nuclear matrix proteins. Cancer Res. 56, 1690-1694.
8. Habuchi, T., Marberger, M., Droller, M. J., Hemstreet, G. P. III, Grossman, H. B., Schalken, J. A., Schmitz-Drager, B. J., Murphy, W. M., Bono, A. V., Goebell, P., Getzenberg, R. H., Hautmann, S. H., Messing, E., Fradet, Y., Lokeshwar, V. B. (2005) Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers. Urology 66, 64-74. <https://doi.org/10.1016/j.urology.2005.08.065>
9. Konety, B. R., Nguyen, T. S., Dhir, R., Day, R. S., Becich, M. J., Stadler, W. M., Getzenberg, R. H. (2000a) Detection of bladder cancer using a novel nuclear matrix protein, BLCA-4. Clin. Cancer Res. 6, 2618-2625.
10. Konety, B. R., Nguyen, T. S., Brenes, G., Sholder, A., Lewis, N., Bastacky, S., Potter, D. M., Getzenberg, R.H. (2000b) Clinical usefulness of the novel marker BLCA-4 for the detection of bladder cancer. J. Urol. 164, 634-639. <https://doi.org/10.1016/S0022-5347(05)67269-2>
11. Lamm, D. L. (2000) The challenge of improved diagnostic and prognostic indicators of superficial bladder cancer. J. Urol. 164, 690-691. <https://doi.org/10.1016/S0022-5347(05)67282-5>
12. Myers-Irvin, J. M., Van Le, T. S., Getzenberg, R. H. (2005a) Mechanistic analysis of the role of BLCA-4 in bladder cancer pathobiology. Cancer Res. 65, 7145-7150. <https://doi.org/10.1158/0008-5472.CAN-05-1142>
13. Myers-Irvin, J. M., Landsittel, D., Getzenberg, R. H. (2005b) Use of the novel marker BLCA-1 for the detection of bladder cancer. J. Urol. 174, 64-68. <https://doi.org/10.1097/01.ju.0000162022.36772.a4>
14. Rosai, E. J. (2004) Rosai and Ackerman’s Surgical Pathology, vol. 1, 9th ed., pp. 137-1359, Elsevier, China.
15. Shirodkar, S. P., Lokeshwar, V. B. (2009) Potential new urinary markers in the early detection of bladder cancer. Curr. Opin. Urol. 19, 488-493. <https://doi.org/10.1097/MOU.0b013e32832eb3a0>
16. Surveillance Epidemiology and End Results Database (2010) http://seer.cancer.gov
17. Van Le, T. S., Myers, J., Konety, B. R., Barder, T., Getzenberg, R. H. (2004) Functional characterization of the bladder cancer marker, BLCA-4. Clin. Cancer Res. 10, 1384-1391. <https://doi.org/10.1158/1078-0432.CCR-0455-03>
18. Van Le, T. S., Miller, R., Barder, T., Babjuk, M., Potter, D. M., Getzenberg, R. H. (2005) Highly specific urine-based marker of bladder cancer. Urology 66, 1256-1260. <https://doi.org/10.1016/j.urology.2005.07.010>
19. Yossepowitch, O., Herr, H. W., Donat, S. M. (2007) Use of urinary biomarkers for bladder cancer surveillance: patient perspectives. J. Urol. 177, 1277–1282. <https://doi.org/10.1016/j.juro.2006.11.066>
20. World Health Organization Classification of Tumours, Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs (2004) eds. Eble, J. N., Sauter, G., Epstein, J. I., Sesterhenn, I. A., pp. 90-109, IARC Press, Lyon.
front cover

ISSN 0015-5500 (Print) ISSN 2533-7602 (Online)

Open access journal

Submissions

Archive